ScienceDaily (Apr. 20, 2010) — Metformin, a mainstay of treatment for patients with type 2 diabetes, may soon play a role in lung cancer prevention if early laboratory research presented at the AACR 101st Annual Meeting 2010 is confirmed in clinical trials.